david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation..: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".